SpectrumX Secures MHRA Licence for Medicinal Specials, Marking a Significant Milestone in Healthcare Innovation
SpectrumX proudly announces the acquisition of its licence, to manufacture and distribute Medicinal Specials, from the Medicines and Healthcare products Regulatory Agency (MHRA). This achievement underscores SpectrumX’s dedication to delivering safe and effective GMP (Good Manufacturing Practice)-compliant healthcare solutions. GMP is the level of compliance major pharmaceuticals companies operate to, and now SpectrumX will be […]
SpectrumX to showcase its groundbreaking, HOCl-based biocidal product Spectricept Care+ at IP2023
16 October 2023 Liverpool – SpectrumX (“the Company”), a UK-based healthcare and pharmaceutical company, today announces that it will be an exhibitor at IP2023, the annual conference for the Infection Prevention Society (IPS), in Liverpool, 17-19 October 2023. The Company will be showcasing its game-changing, alcohol-free hand sanitiser product at booth 3, prominently located […]
